(Training set) | Groups (n) | |||
---|---|---|---|---|
Values | Normal (n = 25) | CP†(n = 25) | PDAC (n = 25) | p- value‡ |
Serum sCD40L (ng/ml) | 9170.5 ± 5449.8* | 17648.9 ± 7264.0 | 30044.2 ± 9747.9 | < 0.001 |
Serum CA19-9 (U/ml) | 7.9 ± 7.1 | 136.8 ± 329.8 | 5795.4 ± 7842.7 | < 0.001 |
Serum CEA (ng/ml) | 2.3 ± 1.5 | 2.9 ± 2.0 | 367.9 ± 1709.4 | 0.428 |
(Validation set) | Groups (n) | |||
Values | Normal (n = 30) | CP (n = 30) | PDAC (n = 55) | p- value ‡ |
Serum sCD40L (ng/ml) | 10540.1 ± 5159.9 | 18709.4 ± 8786.6 | 27924.6 ± 10202.9 | < 0.001 |
Serum CA19-9 (U/ml) | 8.5 ± 7.5 | 119.6 ± 299.7 | 3932.7 ± 6839.2 | < 0.001 |
Serum CEA (ng/ml) | 2.2 ± 1.4 | 2.6 ± 2.0 | 271.4 ± 1246.8 | 0.359 |